Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry (Dexcom Global Registry)
Recruiting
Observational Study
Diabetes
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
2 and older
Sex
Any
Study type
Observational
Participants needed
5,000 (estimated)
Sponsor
DexCom, Inc. · Industry
Who this trial is looking for
This trial is looking for people with diabetes who want to use the Dexcom Continuous Glucose Monitoring System. Participants will need to use the system and provide feedback about their experience.
Are You a Good Fit for This Trial?
You may be able to join if
I meet the requirements to use the Dexcom CGM System.
I have had a HbA1C test in the last 3 months.
I can use the Dexcom CGM System as directed.
I can complete surveys about my experience.
I can follow the study rules.
I can see my healthcare provider at least twice a year.
I or my representative can give written consent to join.
You may not be able to join if
I cannot use the Dexcom CGM System for medical reasons.
The investigator does not think I am a suitable candidate.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
"To evaluate the use of the Dexcom CGM System when used according to approved commercial labeling during standard clinical use and its impact on intended users in a real-world setting"
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Meets Dexcom CGM System Indications for Use (IFU) per approved commercial labeling
* Has at least one HbA1C (Hemoglobin a1c) measurement within three (3) months prior to the Dexcom CGM System use start date that is at least three (3) months after any prior CGM use
* Subject is…
Inclusion Criteria:
* Meets Dexcom CGM System Indications for Use (IFU) per approved commercial labeling
* Has at least one HbA1C (Hemoglobin a1c) measurement within three (3) months prior to the Dexcom CGM System use start date that is at least three (3) months after any prior CGM use
* Subject is willing and able to use Dexcom CGM System according to approved product labeling
* Subject is willing and able to complete applicable patient reported outcome assessments/ surveys
* Subject is willing and able to comply with the protocol
* Subject is willing and able to comply with provider requirements for at least two provider encounters per year according to applicable clinical practice guidelines
* Subject or the subject's legally authorized representative must provide written informed consent prior to any study-related data collection or be enrolled under an IRB/EC approved waiver of consent
Exclusion Criteria:
* Is contraindicated for a Dexcom CGM System per approved commercial labeling
* In the Investigator's opinion, the subject is not considered to be a suitable candidate
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.
